Gujarat Themis Biosyn enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
3,874——
3.13.111.7
16016029.9
4,031——
15715718.2
₹369.93——
448448278
35.7%35.7%10.7%
0.04×——
23.20×——
48.92×——
59.68×——
Reference items — trailing FY values
174166151
82.475.568.8
67.562.663.5
—48.891.0
−124−124−25.1
—−125−25.2
—173116
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

GUJTHEM₹355.55

Gujarat Themis Biosyn Limited

· Pharma & Health
₹ CrorePeersRPGLIFEGUFICBIOORCHPHARMAUNICHEMLABFDCIOLCPMOREPENLABINNOVACAPMcap ₹3,874 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——3,874.3
- Cash, Equiv & ST Investments11.73.13.1
+ Total Debt29.9159.9159.9
Enterprise Value——4,031.0
Net Debt (memo)18.2156.7156.7
EV per Share——369.93
Total Capital278.3447.6447.6
Total Debt/Total Capital10.7435.7135.71
Total Debt/EV——0.04
EV/Sales——23.20
EV/EBITDA——48.92
EV/EBIT——59.68
Reference Items — Trailing FY Values
Sales150.8165.8173.7
EBITDA68.875.582.4
EBIT63.562.667.5
Operating Cash Flow91.048.8—
Free Cash Flow-25.1-123.8-123.8
FCFF (free cash flow to the firm)-25.2-125.3—
Capital Expenditure116.2172.5—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.